Neurologic clinical trials - MUSK 002

Status:

Open (Study open and enrolling)

ClinicalTrials.gov:

NCT03304054

CONDITION(S): Myasthenia Gravis, MuSK antibody, myasthenia gravis with autoantibodies to MuSK - TRIAL: MUSK 002 - A Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Effect of Amifampridine Phosphate in Patients with MuSK Anitbody Positive Myasthenia Gravis, and a Sample of AChR Antibody Postiive Myasthenia Gravis Patients

Trial Type

Interventional

Condition

Myasthenia Gravis MuSK antibody

Keywords

Myasthenia Gravis | Myasthenia Gravis with autoantibodies to MuSK | MuSK antibody